ClinConnect ClinConnect Logo
Search / Trial NCT06458998

Getting To Implementation: Improving Cancer Screening for Veterans

Launched by UNIVERSITY OF PITTSBURGH · Jun 12, 2024

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

Implementation Strategies Patient Navigation Implementation Facilitation Consolidated Framework For Implementation Research Early Detection Of Cancer

ClinConnect Summary

Researchers will conduct two hybrid type 3, cluster-randomized trials to compare the effectiveness of Patient Navigation (PN) and Implementation Facilitation (IF) on hepatocellular cancer (HCC) and colorectal cancer (CRC) screening completion. Trials will enroll 24 sites for the HCC arm and 32 sites for the CRC arm, passively enrolling and cluster-randomizing Veterans by their site of primary care. Multi-level implementation determinants (i.e., barriers and facilitators), preconditions, and moderators will also be evaluated pre- and post-intervention, using Consolidated Framework for Implem...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Veterans:
  • ≥18 years of age
  • Enrolled in Veterans Health Administration (VA)
  • Have ≥1 VA encounter in the prior 18 months
  • Hepatocellular cancer (HCC) screening subgroup: Diagnosis of cirrhosis in electronic medical record
  • Colorectal cancer (CRC) screening subgroup: ≥45 years of age, positive fecal immunochemical test (FIT) (or other screening stool test) in the last 18 months
  • 2. Providers:
  • Healthcare provider or related staff at participating VA site or engaged in CRC or HCC screening pathways in an included VA site (e.g., scheduling)
  • ≥18 years of age
  • Exclusion Criteria:
  • 1. Veterans:
  • \<18 years of age
  • Not enrolled in VA
  • No VA encounters in the prior 18 months
  • Limited life expectancy (\< 6 months), defined as having a code for hospice
  • 2. Providers:
  • Members of the study team will not participate, even if their sites are recruited

About University Of Pittsburgh

The University of Pittsburgh is a leading research institution known for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a robust infrastructure for research and a multidisciplinary approach, the university fosters collaboration among experts in various fields, facilitating the development of novel therapies and interventions. Its clinical trial programs emphasize ethical standards, patient safety, and the integration of cutting-edge technology, making the University of Pittsburgh a pivotal contributor to the landscape of clinical research and a trusted partner in the pursuit of health advancements.

Locations

Pittsburgh, Pennsylvania, United States

Patients applied

0 patients applied

Trial Officials

Shari S Rogal, MD, MPH

Principal Investigator

University of Pittsburgh

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported